Avacta Group (LON:AVCT) Stock Price Passes Below Two Hundred Day Moving Average – Time to Sell?

Avacta Group Plc (LON:AVCTGet Free Report) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 70.71 and traded as low as GBX 66. Avacta Group shares last traded at GBX 68.50, with a volume of 1,317,115 shares trading hands.

Avacta Group Trading Down 3.0%

The company has a debt-to-equity ratio of 602.46, a current ratio of 0.89 and a quick ratio of 4.96. The firm has a market capitalization of £322.83 million, a PE ratio of -7.13 and a beta of 1.12. The business’s 50-day moving average price is GBX 68.10 and its 200-day moving average price is GBX 70.87.

About Avacta Group

(Get Free Report)

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).

Further Reading

Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.